Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.
about
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@ast
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@en
type
label
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@ast
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@en
prefLabel
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@ast
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@en
P2860
P1433
P1476
Safety and metabolic effects o ...... zed, placebo-controlled trial.
@en
P2093
David R Clemmons
Sam Miller
P2860
P304
P356
10.1371/JOURNAL.PONE.0179538
P407
P577
2017-06-15T00:00:00Z